On-Demand Cell Line Development Webinars

  1. From Data To Decisions: AI And Multi-Omics For Cell Culture Development 8/13/2026

    See how combining multi-omics data, AI-enabled analytics, and expertise can reveal the biological drivers of process performance, helping biologics developers identify optimization opportunities.

  2. Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid 7/23/2026

    Learn how rational plasmid engineering and promoter optimization can significantly improve AAV productivity while reducing plasmid burden, paving the way for more efficient and scalable viral vector manufacturing.

  3. Leveraging 3Rs For Superior Cell Line Characterization 7/13/2026

    Explore how non-animal methods, including next generation sequencing, are advancing biologics safety testing through the 3Rs while supporting faster adventitious virus testing and more.

  4. Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity 6/30/2026

    A bottom-up, data-driven media design approach shows how targeted nutrient optimization overcomes metabolic limits to boost culture performance and titer while maintaining product quality and process consistency.

  5. Generate Stable High-Producing Clones In 14 Weeks 6/18/2026

    Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

  6. Elevate Your Protein Production With SynWeave™ 6/15/2026

    Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.

  7. Streamlining Discovery And Development Workflows Using Engineered P. fluorescens Strains For ncAA Incorporation And Extracellular Protein Production 6/8/2026

    Pseudomonas fluorescens offers a purpose-built alternative to conventional expression systems. Strain engineering platforms built around this organism can improve yields and simplify process development.

  8. Accelerating Antibody Development: A Proven Path From Gene To GMP 6/5/2026

    Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.

  9. From Gene Editing To NGS-Based T Cell Characterization 6/4/2026

    Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

  10. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

    This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.